Koolen-de Vries syndrome is a genetic condition that affects development and learning. Many people with Koolen-de Vries syndrome have low muscle tone in infancy and later speech and motor delays. Features can include mild to moderate intellectual disability, friendly social behavior, and sometimes seizures or heart and kidney differences. It is lifelong, and signs are usually noticed in infancy or early childhood, though they vary from person to person. Care focuses on therapies, educational support, and treating specific issues, and most people can live into adulthood with appropriate care.
Overview
Koolen-de vries syndromeSymptoms
Early signs of Koolen-de Vries syndrome include low muscle tone and feeding trouble in infancy, followed by developmental and speech delays; many have friendly social style, mild–moderate learning disability, seizures, joint laxity, facial traits, and occasional heart or kidney differences.
Outlook and prognosis
Most children with Koolen-de Vries syndrome make steady developmental gains, though milestones usually arrive later than peers. Many grow into adults who communicate, learn practical skills, and enjoy good quality of life with tailored therapies. Lifespan is typically near typical, barring significant medical complications.
Causes and risk factors
Koolen-de Vries syndrome results from a KANSL1 gene change or a small deletion on chromosome 17. Most cases are new (de novo); rarely, an affected parent passes it on in an autosomal-dominant way. No environmental or lifestyle risk factors known.
Genetic influences
Genetics is central in Koolen-de Vries syndrome, usually caused by a missing piece of chromosome 17 or a change in the KANSL1 gene. Most cases are de novo, though it can be inherited rarely. Genetic testing confirms diagnosis and guides family planning.
Diagnosis
Doctors suspect Koolen-de Vries syndrome based on developmental history, distinctive facial features, and other clinical findings. Genetic tests confirm the diagnosis of Koolen-de Vries syndrome. Brain or heart imaging may assess associated features.
Treatment and drugs
Treatment for Koolen-de Vries syndrome focuses on each person’s needs, often combining early developmental therapies, educational supports, and physical, occupational, and speech therapy. Doctors may address seizures, feeding issues, sleep problems, or mood symptoms with targeted medications. Regular follow-up with genetics, neurology, cardiology, and other specialists helps adjust care over time.
Symptoms
Koolen‑de Vries syndrome affects early development, often showing up day to day as trouble feeding in infancy, low muscle tone, and later milestones for sitting, walking, and talking. Early features of Koolen‑de Vries syndrome can also include a warm, friendly social style and distinctive facial traits that help clinicians recognize it. Features vary from person to person and can change over time.
Many children sit, crawl, and walk later than peers. Therapies like physical and occupational therapy often help build skills. Timing varies widely.
In Koolen‑de Vries syndrome, expressive speech is often more affected than understanding. Some children use gestures or communication devices while speech develops. Speech therapy is usually part of care.
Babies may feel floppy and have poor head control. Older children can tire easily, with clumsiness or slow, effortful movements. Strength and tone often improve with targeted therapy.
In infancy, weak suck and reflux can make feeding slow. Some need thickened feeds or temporary tube support to grow well. Feeding usually becomes easier with time and guidance.
How people usually first notice Koolen-de vries syndrome?
Many families first notice Koolen-de Vries syndrome in infancy because a baby seems unusually calm with low muscle tone, feeding slowly, or taking longer to meet early motor milestones like rolling or sitting. As toddlers, delayed speech and language, easygoing temperament, and mild facial traits (such as a broad nose tip, upturned eyebrows, or a friendly, open expression) may prompt a developmental evaluation. Doctors often connect the dots through a combination of developmental delays, hypotonia, and sometimes congenital features on exam, with genetic testing confirming the diagnosis—these are the first signs of Koolen-de Vries syndrome and how it’s usually first noticed.
Types of Koolen-de vries syndrome
Koolen-de Vries syndrome can look a bit different from one person to another. Most have a shared core profile—developmental delay, low muscle tone in infancy, and friendly social behavior—but the cause can come from two related genetic changes that influence severity in subtle ways. Clinicians often describe them in these categories: the recurrent 17q21.31 microdeletion and single-gene KANSL1 variants. Not everyone will experience every type of symptom, and early symptoms of Koolen-de Vries syndrome may change as children grow.
17q21.31 deletion
This is the most common cause and involves a small missing segment on chromosome 17 that includes KANSL1. Many have global developmental delay, low muscle tone, and later speech, with a warm, social temperament. Medical features can include feeding issues in infancy, joint flexibility, and occasional heart or kidney differences.
KANSL1 sequence variant
Here, the KANSL1 gene itself has a change rather than being deleted. Features often overlap with the deletion type, including motor and speech delays and hypotonia. Some studies suggest similar overall outcomes, though individual severity can vary from mild to more pronounced.
Mosaic presentations
In rare cases, only a portion of cells carry the deletion or gene change. Symptoms may be milder or more uneven across skills, depending on how many cells are affected and in which tissues. Loved ones may recognize certain types sooner than the person experiencing them.
Family recurrence context
Most cases are new (de novo), but very rarely a parent has a balanced chromosome change or low-level mosaicism. When this happens, patterns in relatives can differ, and recurrence risk is higher. Discussing variants of Koolen-de Vries syndrome with a genetics team can clarify risks and testing options.
What genetics can tell you about symptoms
Some people with Koolen-de Vries syndrome who have larger 17q21.31 deletions tend to show more pronounced developmental delay, low muscle tone, and feeding or speech challenges. Variants limited to the KANSL1 gene can bring milder delays but similar friendly social behavior and distinctive facial features.
Causes and risk factors
Most cases are caused by a tiny missing piece of chromosome 17 that disrupts a gene called KANSL1.
Some are caused by a single change inside KANSL1.
This usually happens as a new change at conception and is not linked to lifestyle or pregnancy exposures.
When inherited, a parent with the change has a 50% chance to pass it to each child, so family history is the main risk factor for Koolen-de Vries syndrome.
Some risks are written in our DNA, passed down through families.
Environmental and biological risk factors
Koolen-de Vries syndrome starts before birth, so risks relate to events in egg or sperm formation and very early development. Doctors often group risks into internal (biological) and external (environmental). Below are the environmental and biological risk factors for Koolen-de Vries syndrome as currently understood.
As egg and sperm cells age, new chromosomal changes become slightly more likely. This may modestly raise the chance of Koolen-de Vries syndrome, though the absolute risk for any pregnancy remains low.
Many cases result from a one-time change that happens by chance during formation of the egg or sperm. This is a biological event that parents cannot predict or prevent.
No specific toxins, infections, medications, or radiation levels have been shown to increase risk for this syndrome. Everyday home or workplace exposures have not been linked in available research.
Genetic risk factors
Koolen-de Vries syndrome is most often caused by a tiny missing segment on chromosome 17 that removes the KANSL1 gene. Less often, a small change within the KANSL1 gene itself leads to the same effect. Some risk factors are inherited through our genes. Understanding the genetic causes of Koolen-de Vries syndrome helps families discuss testing and plan future pregnancies.
17q21.31 microdeletion: This is the most common cause, where a small stretch of chromosome 17 is missing. The deletion removes KANSL1 and nearby DNA, leading to the features of the condition. It typically arises for the first time in the child.
KANSL1 variants: A spelling change within the KANSL1 gene can disrupt how the gene works. This rarer cause produces the same diagnosis as the deletion. It may occur de novo or be inherited.
Autosomal dominant: When a parent has Koolen-de Vries syndrome, each pregnancy has a 50% chance of inheriting the genetic change. This applies to both boys and girls equally. Features can vary between relatives.
De novo changes: Most children with Koolen-de Vries syndrome have a genetic change that is new and not found in either parent. In these families, the chance of it happening again is low.
Germline mosaicism: Rarely, a parent’s eggs or sperm carry the change in a small percentage, even when their blood test is normal. This can slightly raise the recurrence risk above the general population. Targeted testing and follow-up can help clarify this.
17q21.31 inversion: A common, harmless flip in the DNA orientation near KANSL1 can make the deletion more likely during egg or sperm formation. Many people carry this inversion and never have a child with the syndrome. The absolute risk remains very small.
Family history: Having an affected parent, sibling, or relative signals a higher chance that the same genetic change could appear again in the family. Testing parents helps refine the recurrence risk for future pregnancies.
KANSL1 dosage: Both the deletion and gene variants reduce the working amount of KANSL1. Too little KANSL1 disrupts brain and body development and defines the syndrome.
Lifestyle risk factors
Koolen-de Vries syndrome is a genetic condition; lifestyle habits do not cause it, but they can shape day‑to‑day function, symptoms, and complications. This overview focuses on how lifestyle affects Koolen-de Vries syndrome and clarifies that lifestyle risk factors for Koolen-de vries syndrome are about management, not causation. Because features vary, tailor choices with your clinicians, therapists, and educators. The elements below link common lifestyle areas to tangible effects on motor skills, behavior, sleep, growth, and safety in KdVS.
Regular, low‑impact activity (walks, swimming, cycling) can improve muscle tone, balance, and endurance in KdVS. Better strength and coordination may reduce falls and support greater independence.
Hypermobility and hypotonia mean high‑impact or twisting sports can raise injury and pain risk. Choosing supportive footwear, orthotics, and controlled-strength training helps stabilize joints and maintain mobility.
Calorie-dense, frequent meals in infancy can support growth when feeding is slow or inefficient. Later, balanced protein and healthy fats help maintain muscle tone and energy for therapies and school.
Adequate fiber, fluids, and routine toileting can reduce constipation, which is common in KdVS. Better bowel habits may improve comfort, appetite, and participation in therapies.
Risk prevention
Koolen-de Vries syndrome is a genetic condition present from birth, so the condition itself can’t be prevented. Prevention focuses on avoiding complications, catching problems early, and supporting development at each stage. Prevention works best when combined with regular check-ups. A coordinated plan with pediatrics, genetics, and therapists can reduce hospital visits and improve quality of life.
Learn about recurrence risk and reproductive options for future pregnancies. Options may include prenatal testing or IVF with embryo testing to lower the chance of passing on the genetic change.
At diagnosis, set up baseline checks such as heart and kidney imaging, hearing tests, and feeding support. This helps spot issues early and guides follow-up.
Start physical, occupational, and speech therapy as soon as delays are noticed. Learning to recognize early symptoms of Koolen-de Vries syndrome can speed referrals and improve outcomes.
Ask about seizure risk and what signs to watch for, such as staring spells or sudden stiffening. A clear plan, including when to seek EEG testing and how to use rescue medicine, can prevent emergencies.
Transmission
Koolen-de Vries syndrome is not contagious; it can’t be caught or passed through casual contact. It arises from a change affecting one copy of a gene on chromosome 17, and in most families this change occurs for the first time in the child. Less often, the change is inherited from a parent who has the same change or the syndrome; in that situation, each child has a 50% (1 in 2) chance of inheriting it. When neither parent has the change on testing, the chance of having another child with Koolen-de Vries syndrome is low, although a small risk remains because some egg or sperm cells can carry the change. This is how Koolen-de Vries syndrome is inherited; if questions about genetic transmission of Koolen-de Vries syndrome come up for your family, a genetic counselor or clinical geneticist can help review options.
When to test your genes
Consider genetic testing if a child shows developmental delay, low muscle tone, feeding difficulties, or distinctive facial features, or if a clinician suspects Koolen-de Vries syndrome. Testing also helps guide care and therapies, and informs recurrence risk for future pregnancies. Talk with a genetics professional to choose the right test.
Diagnosis
Diagnosis of Koolen-de Vries syndrome (KdVS) usually starts with noticing a pattern of developmental delays, low muscle tone, and characteristic facial features, often alongside feeding or learning challenges. Doctors then confirm the condition with genetic tests that look for changes in a gene called KANSL1 or a small missing piece of chromosome 17. Genetic testing may be offered to clarify risk or guide treatment. When features are suggestive, the genetic diagnosis of Koolen-de Vries syndrome can be made with one of several reliable test methods.
Providers look for developmental delay, low muscle tone, feeding difficulties, and a friendly social style with a distinctive facial appearance. When these features cluster together, they raise suspicion for Koolen-de Vries syndrome and prompt testing.
This test can detect a small missing segment at 17q21.31 that includes the KANSL1 gene. Finding this microdeletion often establishes the genetic diagnosis of Koolen-de Vries syndrome.
If a deletion is not found, sequencing checks the KANSL1 gene for disease-causing changes. Identifying a pathogenic variant confirms KdVS due to a single-gene change.
Broader testing can be helpful when the picture is unclear or more than one condition is being considered. These tests can identify KANSL1 variants and sometimes detect the 17q21.31 region change.
Stages of Koolen-de vries syndrome
Koolen-de vries syndrome does not have defined progression stages. It is present from birth and tends to vary widely from person to person, with development changing over time rather than moving through set steps. Doctors usually confirm the diagnosis with a detailed exam, a review of early symptoms of Koolen-de vries syndrome like low muscle tone and developmental delays, and genetic testing for changes in the 17q21.31 region or the KANSL1 gene. Different tests may be suggested to help build a clear picture, and ongoing follow-up with specialists tracks progress and supports learning, movement, and overall health.
Outlook and prognosis
Looking at the long-term picture can be helpful. Many living with Koolen-de Vries syndrome grow and learn at their own pace, with strengths in social engagement and challenges that often include low muscle tone, developmental delay, and learning differences. Early care can make a real difference, especially when therapies start in infancy or early childhood to support feeding, speech, motor skills, and school learning. Some people experience seizures or heart or kidney issues, while others have fewer medical complications; regular checkups help catch and manage problems early.
The outlook is not the same for everyone, but most people with Koolen-de Vries syndrome are expected to live into adulthood, and current reports do not suggest a shortened life span solely due to the syndrome. Independence varies: some adults live semi-independently with supports, while others need lifelong daily assistance. Early symptoms of Koolen-de Vries syndrome—such as feeding difficulties, delayed walking, or speech delay—don’t predict everything about adulthood, so progress over time matters more than any single milestone. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including access to therapies, educational supports, seizure control, and management of any heart or kidney concerns.
With ongoing care, many people maintain good overall health and continue to gain new skills well into adolescence and adulthood. Families often want to know what role they can play.. Keeping routines, coordinating therapies, and planning for transitions—like adult services, job training, or supported living—can set the stage for the best possible independence. Talk with your doctor about what your personal outlook might look like, including plans for monitoring seizures, hearing and vision, cardiac health, and sleep, as these can influence day-to-day functioning and long-term quality of life.
Long-term effects
Koolen-de Vries syndrome is a lifelong genetic condition. Long-term effects vary widely, and support needs can change with age. Many grow into friendly, social adults, though learning, speech, and motor challenges usually remain to some degree. Most have a near-normal life expectancy with Koolen-de Vries syndrome, and severe complications are uncommon.
Intellectual disability usually ranges from mild to moderate. Reading, math, and day-to-day skills tend to improve slowly over childhood and adolescence. Adult independence varies.
First words are delayed, and expressive speech often stays limited. Understanding language is typically stronger than speaking. Many rely on short phrases or alternative ways to communicate.
Low muscle tone and flexible joints make early motor milestones late. Walking is common, but balance, coordination, and stamina can remain reduced.
About one-third develop seizures, usually starting in childhood. Many experience long seizure-free periods or see episodes lessen over time.
How is it to live with Koolen-de vries syndrome?
Living with Koolen-de Vries syndrome often means navigating developmental differences at a gentle, steady pace: delays in speech and motor skills, learning challenges, and sometimes low muscle tone can shape daily routines at home, school, and work. Many find that structured supports—speech and physical therapy, individualized education plans, and clear, predictable schedules—help build skills and confidence, while social strengths and a warm, engaging personality are common bright spots. Families, siblings, and caregivers may adjust plans more often, advocate in medical and educational settings, and coordinate therapies, but many also describe a close-knit rhythm that grows around the person’s needs and strengths. With early intervention, patient specialists, and community networks, people with Koolen-de Vries syndrome can make meaningful progress and participate in school, friendships, and family life.
Treatment and drugs
Treatment for Koolen-de Vries syndrome focuses on supporting development, managing symptoms, and preventing complications rather than curing the condition. Care usually starts early and involves a team approach—speech and language therapy, physiotherapy, and occupational therapy help with communication, motor skills, and daily activities, while educational supports address learning needs. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as medicines for seizures, attention or behavior challenges, reflux, constipation, sleep issues, or anxiety, chosen and adjusted based on each person’s needs. Regular hearing and vision checks, heart and kidney evaluations, and monitoring of growth, feeding, and spine alignment help catch and treat problems early. Not every treatment works the same way for every person, so plans are reviewed over time and updated as children grow into adulthood.
Non-drug treatment
Many families look for practical, hands-on supports that help with movement, communication, learning, and daily living. Non-drug treatments often lay the foundation for progress at home, school, and in the community. With Koolen-de vries syndrome, therapies are tailored to each person’s strengths and needs, and adjusted over time. Early, steady support can improve comfort, independence, and quality of life.
Starting services in infancy or as soon as early symptoms of Koolen-de vries syndrome appear can boost development. A coordinated plan often includes physical, occupational, and speech therapy.
Targeted exercises build core strength, balance, and coordination. For people with Koolen-de vries syndrome, this can support later skills like walking, running, and playground activities.
Practice with fine-motor skills helps with feeding, dressing, and writing. Therapists also teach energy-saving ways to handle daily tasks for Koolen-de vries syndrome.
Therapy focuses on speech sounds, understanding language, and social communication. For many with Koolen-de vries syndrome, ongoing support helps expand vocabulary and confidence.
Your genes may have an impact on how drugs work for you
Medications used in Koolen-de Vries syndrome can work differently from person to person because small DNA differences affect how fast the body breaks down a drug or how strongly the brain responds. Pharmacogenetic testing, when available, may guide safer doses and reduce side effects.
Pharmacological treatments
Living with Koolen-de vries syndrome often means managing day-to-day issues like seizures, attention and sleep challenges, drooling, reflux, and constipation. Drugs that target symptoms directly are called symptomatic treatments. For families navigating early symptoms of Koolen-de vries syndrome such as seizures or reflux, certain medicines can ease routines and improve comfort. Your care team will tailor choices to age, other health needs, and how each medicine is tolerated.
Levetiracetam, valproate, or lamotrigine are commonly used to prevent seizures in Koolen-de vries syndrome. Doses are adjusted slowly to balance seizure control with side effects.
Diazepam rectal gel or midazolam nasal spray can stop a prolonged seizure. Families are often taught when and how to give these at home.
Methylphenidate or mixed amphetamine salts can improve focus and reduce hyperactivity. Guanfacine, clonidine, or atomoxetine are options if stimulants aren’t a good fit.
Selective serotonin reuptake inhibitors such as sertraline or fluoxetine can help with persistent anxiety or low mood. Start low and increase gradually while watching for side effects.
Genetic influences
Koolen-de Vries syndrome usually stems from a small missing piece of chromosome 17 (called 17q21.31) that includes a gene named KANSL1, or from a direct change in KANSL1 itself. A change in just one copy is enough to cause the condition, but in most families it happens for the first time in the child rather than being inherited from a parent. The chance of it happening again in a family is usually low; a genetics team can check for rare situations in which a parent carries a rearrangement or has the change in some egg or sperm cells. People who share the same genetic cause of Koolen-de Vries syndrome can still be affected in different ways and to different degrees. DNA testing can sometimes identify these changes. Understanding the genetic cause of Koolen-de Vries syndrome can guide care, family planning, and choices about testing for relatives.
Is Koolen-de vries syndrome genetic?
Genetics is central in Koolen-de Vries syndrome, usually caused by a missing piece of chromosome 17 or a change in the KANSL1 gene. Most cases are de novo, though it can be inherited rarely. Genetic testing confirms diagnosis and guides family planning.
Pharmacogenetics—how genetics influence drug effects
For people with Koolen‑de Vries syndrome, medicines are chosen to manage specific needs like seizures, attention and behavior, anxiety, sleep, and reflux, and dosing is often adjusted gradually to balance benefit and side effects. The genetic change that causes Koolen‑de Vries syndrome doesn’t usually determine how the liver breaks down most drugs, but your separate drug‑metabolism genes can. Variants in common liver enzyme genes may affect dosing or side effects with atomoxetine, many antidepressants, and several anti‑seizure medicines. For carbamazepine or phenytoin, a specific immune‑system gene variant, seen more often in people of Asian ancestry, can raise the risk of severe skin reactions, so doctors may recommend a one‑time safety test before starting. Phenytoin dosing and side effects can also depend on how quickly your body metabolizes it, and some people need much lower doses. Alongside medical history and current medicines, genetic testing can help tailor choices and avoid side effects in Koolen‑de Vries syndrome. Even with genetic results, doctors also weigh everyday clinical factors—such as low muscle tone, constipation, or heart differences—to choose what’s safest and best tolerated.
Interactions with other conditions
People living with Koolen-de Vries syndrome often have other health issues as well, and the mix can shape day-to-day life—from school support to medication choices. Doctors call it a “comorbidity” when two conditions occur together. Epilepsy, for example, can make attention and learning challenges feel tougher on days when seizures or medication side effects are more noticeable. In Koolen-de Vries syndrome, low muscle tone can affect swallowing and sleep; reflux or sleep apnea may raise the chance of chest infections, especially during a cold. Heart or kidney differences can also influence which medicines are safest when treating seizures, infections, or behavior symptoms. Because traits can overlap with autism or ADHD, therapies for communication, sensory needs, and routines often help across conditions, but plans should be individualized.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who were slower to talk, gentle in temperament, and needed extra support to learn, often alongside distinctive facial features. Families and communities once noticed patterns, recalling relatives who shared similar traits across generations without a clear name or cause. Early pediatric case notes captured these observations, but they could not connect them to a single condition.
From early theories to modern research, the story of Koolen‑de Vries syndrome has unfolded step by step. First described in the medical literature as a cluster of developmental differences and a recurring deletion on chromosome 17, it was initially recognized through careful clinical observation. In the 1990s and early 2000s, better chromosome testing began to reveal a small missing piece at 17q21.31 in some people with these features. Building on this early work, scientists later found that changes in a gene within this region, called KANSL1, could also lead to the same pattern when the DNA piece wasn’t missing but the gene itself was altered.
As medical science evolved, descriptions became more consistent. Clinicians noted a recognizable facial appearance in many with Koolen‑de Vries syndrome, along with low muscle tone in infancy, delayed speech, and learning differences of varying degrees. Some had feeding difficulties, seizures, or heart or kidney differences, while others had milder courses. This variability helped explain why the condition was likely overlooked or given different labels in the past.
In recent decades, awareness has grown as genetic testing became more accessible. Chromosomal microarray and gene sequencing allowed doctors to confirm the diagnosis in children and adults who previously had only descriptive labels. With each decade, published reports expanded the picture, showing that Koolen‑de Vries syndrome occurs worldwide and across ethnic backgrounds, and that people can thrive with tailored supports.
Knowing the condition’s history highlights how observation, family stories, and advances in genetics came together. What began as scattered case descriptions became a clearly defined condition once the shared genetic cause was uncovered. Today, the name Koolen‑de Vries syndrome reflects the researchers who helped establish its defining features and genetic basis, and it anchors ongoing efforts to better understand long‑term outcomes and supports for those living with it.